The CLSA COVID-19 Antibody Study studies the impact of COVID-19 among older adults in Canada, a population that has been shown to be at greatest risk for severe outcomes from COVID-19 disease. The study collected blood samples from CLSA participants to estimate levels of immunity among older adults and provide a deeper understanding of some of the factors that affect their experience of the disease.